Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer

References

• Roodhart JM, Daenen LG, Stigter EC, Prins HJ, Gerrits J, Houthuijzen JM, Gerritsen MG, Schipper HS, Backer MJ, van Amersfoort M, et al. Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids. Cancer Cell 2011; 20(3):370-83; PMID:21907927; http://dx.doi.org/10.1016/j.ccr.2011.08.010
   PubMed Web of Science ®Google Scholar
• Cukierman E, Bassi DE. The mesenchymal tumor microenvironment: a drug-resistant niche. Cell Adh Migr 2012; 6(3):285-96; PMID:22568991; http://dx.doi.org/10.4161/cam.20210
   PubMed Web of Science ®Google Scholar
• Zhu W, Huang L, Li Y, Qian H, Shan X, Yan Y, Mao F, Wu X, Xu WR. Mesenchymal stem cell-secreted soluble signaling molecules potentiate tumor growth. Cell Cycle 2011; 10(18):3198-207; PMID:21900753; http://dx.doi.org/10.4161/cc.10.18.17638
   PubMed Web of Science ®Google Scholar
• Zhu W, Huang L, Li Y, Zhang X, Gu J, Yan Y, Xu X, Wang M, Qian H, Xu W. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett 2012; 315(1):28-37; PMID:22055459; http://dx.doi.org/10.1016/j.canlet.2011.10.002
   PubMed Web of Science ®Google Scholar
• Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, Wang M, Zhou Y, Zhu W, Li W, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev 2013; 22(6):845-54; PMID:23002959; http://dx.doi.org/10.1089/scd.2012.0395
   PubMed Web of Science ®Google Scholar
• Zhou Y, Xu H, Xu W, Wang B, Wu H, Tao Y, Zhang B, Wang M, Mao F, Yan Y, et al. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res Ther 2013 Apr; 4(2):34; http://dx.doi.org/10.1186/scrt194
   PubMed Web of Science ®Google Scholar
• Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev 2013 Dec; 32(3-4): 623-42; http://dx.doi.org/10.1007/s10555-013-9441-9
   PubMed Web of Science ®Google Scholar
• Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 2013; 501(7467):346-54; PMID:24048067; http://dx.doi.org/10.1038/nature12626
   PubMed Web of Science ®Google Scholar
• Corcoran C, Rani S, O'Brien K, O'Neill A, Prencipe M, Sheikh R, Webb G, McDermott R, Watson W, Crown J, et al. Docetaxelresistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes. PLoS One 2012; 7(12):e50999; http://dx.doi.org/10.1371/journal.pone.0050999
   PubMed Web of Science ®Google Scholar
• Xiao X, Yu S, Li S, Wu J, Ma R, Cao H, Zhu Y, Feng J. Exosomes: decreased sensitivity of lung cancer A549 cells to cisplatin. PLoS One 2014; 9(2):e89534; PMID:24586853; http://dx.doi.org/10.1371/journal.pone.0089534
   PubMed Web of Science ®Google Scholar
• Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res 2003; 63(15):4331-7; PMID:12907600
   PubMed Web of Science ®Google Scholar
• Sun J, Song Y, Wang Z, Chen X, Gao P, Xu Y, Zhou B, Xu H. Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis. BMC Cancer 2013; 13:577; PMID:24304886; http://dx.doi.org/10.1186/1471-2407-13-577
   PubMed Web of Science ®Google Scholar
• Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J, Savastano B, Mabilia A, et al. Treatment of gastric cancer. World J Gastroenterol 2014; 20(7):1635-49; PMID:24587643; http://dx.doi.org/10.3748/wjg.v20.i7.1635
   PubMed Web of Science ®Google Scholar
• Kwee RM, Kwee TC. Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer. World J Gastroenterol 2014; 20(7):1650-56; PMID:24587644; http://dx.doi.org/10.3748/wjg.v20.i7.1650
   PubMed Web of Science ®Google Scholar
• Chien J, Kuang R, Landen C, Shridhar V. Platinum-sensitive recurrence in ovarian cancer: the role of tumor microenvironment. Front Oncol 2013; 3:251; PMID:24069583; http://dx.doi.org/10.3389/fonc.2013.00251
   PubMedGoogle Scholar
• Mao Y, Keller ET, Garfield DH, Shen K, Wang J. Stromal cells in tumor microenvironment and breast cancer. Cancer Metastasis Rev 2013; 32(1-2):303-15; PMID:23114846; http://dx.doi.org/10.1007/s10555-012-9415-3
   PubMed Web of Science ®Google Scholar
• Qiao C, Xu W, Zhu W, Hu J, Qian H, Yin Q, Jiang R, Yan Y, Mao F, Yang H, et al. Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol Int 2008; 32(1):8-15; PMID:17904875; http://dx.doi.org/10.1016/j.cellbi.2007.08.002
   PubMed Web of Science ®Google Scholar
• Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 2013 Oct; 13(10):714-26; http://dx.doi.org/10.1038/nrc3599
   PubMed Web of Science ®Google Scholar
• Riganti C, Doublier S, Viarisio D, Miraglia E, Pescarmona G, Ghigo D, Bosia A. Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1aand P-glycoprotein overexpression. Br J Pharmacol 2009; 156(7):1054-66; PMID:19298255; http://dx.doi.org/10.1111/j.1476-5381.2009.00117.x
   PubMed Web of Science ®Google Scholar
• Guan J, Chen J. Mesenchymal stem cells in the tumor microenvironment. Biomed Rep 2013; 1(4):517-21; PMID:24648978
   PubMedGoogle Scholar
• Houthuijzen JM, Daenen LG, Roodhart JM, Voest EE. The role of mesenchymal stem cells in anti-cancer drug resistance and tumor progression. Br J Cancer 2012; 106(12):1901-6; PMID:22596239; http://dx.doi.org/10.1038/bjc.2012.201
   PubMed Web of Science ®Google Scholar
• Sanchez CG, Penfornis P, Oskowitz AZ, Boonjindasup AG, Cai DZ, Dhule SS, Rowan BG, Kelekar A, Krause DS, Pochampally RR. Activation of autophagy in mesenchymal stem cells provides tumor stromal support. Carcinogenesis 2011; 32:964-72; PMID:21317300; http://dx.doi.org/10.1093/carcin/bgr029
   PubMed Web of Science ®Google Scholar
• De Boeck A, Pauwels P, Hensen K, Rummens JL, Westbroek W, Hendrix A, Maynard D, Denys H, Lambein K, Braems G, et al. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling. Gut 2013; 62:550-60; PMID:22535374; http://dx.doi.org/10.1136/gutjnl-2011-301393
   PubMed Web of Science ®Google Scholar
• Vianello F, Villanova F, Tisato V, Lymperi S, Ho KK, Gomes AR, Marin D, Bonnet D, Apperley J, Lam EW, et al. Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis. Haematologica 2010; 95(7):1081-9; PMID:20179085; http://dx.doi.org/10.3324/haematol.2009.017178
   PubMed Web of Science ®Google Scholar
• Rodriguez-Mora O, LaHair MM, Howe CJ, McCubrey JA, Franklin RA. Calcium/calmodulin-dependent protein kinases as potential targets in cancer therapy. Expert Opin Ther Targets 2005; 9(4):791-808; PMID:16083343; http://dx.doi.org/10.1517/14728222.9.4.791
   PubMed Web of Science ®Google Scholar
• McCubrey JA, Abrams SL, Stadelman K, Chappell WH, Lahair M, Ferland RA, Steelman LS. Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells. Adv Enzyme Regul 2010; 50(1):285-307; PMID:19895837; http://dx.doi.org/10.1016/j.advenzreg.2009.10.016
   PubMedGoogle Scholar
• Boelens MC, Wu TJ, Nabet BY, Xu B, Qiu Y, Yoon T, Azzam DJ, Victor CTS, Wiemann BZ, Ishwaran H, et al. Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways. Cell 2014; 159(3):499-513; PMID:25417103; http://dx.doi.org/10.1016/j.cell.2014.09.051
   PubMed Web of Science ®Google Scholar
• Wang J, Hendrix A, Hernot S, Lemaire M, Bruyne ED, Valckenborgh EV, Lahoutte T, Wever OD, Vanderkerken K, Menu E. Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells. Blood 2014; 124(4):555-66; PMID:24928860; http://dx.doi.org/10.1182/blood-2014-03-562439
   PubMed Web of Science ®Google Scholar
• Shelke GV, Lässer C, Gho YS, Lötvall J. Importance of exosome depletion protocols to eliminate functional and RNA-containing extracellular vesicles from fetal bovine serum. J Extracell Vesicles 2014; 3:24783.
   PubMedGoogle Scholar